1124results about How to "Good anti-inflammatory effect" patented technology

The present invention provides an ophthalmic aqueous pharmaceutical preparation, which is excellent in anti-inflammatory effect, which is less stimulative and which has high safety and excellent storage stability. The ophthalmic aqueous pharmaceutical preparation comprises meloxicam and trometamol.

A compound of the formula (I):wherein R is hydrogen or C2-6 alkanoyl; X is halogen; and ring A is benzene ring which is optionally substituted by 1 to 4 substituents selected from {circle around (1)} halogen, {circle around (2)} hydroxy, {circle around (3)} C1-6 alkoxy optionally substituted by halogen or phenyl, {circle around (4)} C1-6 alkylthio optionally substituted by halogen or phenyl, {circle around (5)} C1-6 alkyl optionally substituted by halogen, {circle around (6)} C2-6 alkanoylamino or {circle around (7)} carboxy optionally esterified by C1-6 alkyl, or a salt thereof; which can be used for preventing or treating inflammatory disease, arthritis, chronic rheumatoid arthritis, autoimmune diseases, or rejection after organ transplantation.

Compositions and systems for topical ophthalmic application, which include an aqueous mixture of steroidal and non-steroidal anti-inflammatory agents in a flowable mucoadhesive polymer, for treating inflammation and inflammatory conditions of the eye.

The invention provides a traditional Chinese medicine composition for treating colpitis mycotica, wherein the oral medicines are: 10-20 parts of viscum album, 10-20 parts of angelica, 10-20 of bighead atractylodes rhizome, 10-20 parts of motherwort, 10-20 of astragalus root, 10-20 parts of fructus zizyphi sativae, 10-20 parts of semen cuscutae, 10-20 parts of fruit of glossy privet, 10-20 of mulberry, 10-20 parts of rhizoma anemarrhenae, 10-20 of fructus rubi, 10-20 parts of Chinese magnoliavine fruit, 10-20 parts of scutellaria baicalensis, and 10-20 parts of patrinia; the external medicines are: 10-30 parts of root of Chinese pulsatilla, 10-30 parts of golden cypress, 10-30 parts of radix sophorae flavescentis, 10-30 parts of fructus cnidii, 10-30 parts of cortex dictamni, 10-30 parts of folium artemisiae argyi, 10-30 parts of clove, 10-30 parts of Chinese prickly ash, 10-30 parts of smoked plum, 10-30 parts of rhizoma smilacis glabrae, 10-30 parts of borneol, 10-30 parts of herba, and 10-30 parts of mint. The composition has fast effects of relieving itching, killing insect and degerming, strongly diminishes inflammation antibiotic property, and is high in bacteriostasis ratio, convenient for administration, easy for manufacturing and low in cost.

The invention provides a high-energy enteral nutrition multi polymerizer. The total energy of every 100g of the multi polymerizer is 450-500kJ. The energy ratio is as follows: 16-20% of protein, 35-50% of fat and 40-50% of carbohydrate. The multi polymerizer has the advantages of high fat, high energy, low carbohydrate and rich nutrition, meets the nutritional treatment guideline of modern medicine relevant to malignant tumor, has the obvious anti-tumor effect, and can improve the nutrition condition of tumor patients.

The invention relates to a dermatological pharmaceutical composition for the treatment of skin inflammation diseases, such as dermatitis, atopic dermatitis, vitiligo, alopecia areata, acne, psoriasis and pruritus. The invention comprises a base anti-inflammatory agent, such as indometacin; one or more optional active ingredients selected alternatively from among at least a corticoid and an antibiotic; and a combination of topical antioxidants used to potentiate the anti-inflammatory effect, selected from among green tea, lipoic acid, curcumin, ascorbyl palmitate, Coenzyme Q10, resveratrol, Pycnogenol™, L-camosine, taurine, vitamin E, vitamin C, papaya extract, isoflavones, manganese, lycopene and quercetin. At least one of the topical antioxidants is a peroxisome proliferator-activated receptor-gamma (PPAR-γ) activator. The invention also includes at least one antioxidant substance with an antiproliferative effect on keratonocytes, e.g. manganese, and at least one substance that blocks tumour necrosis factor-alpha (TNF-α) or other cytokines that provoke the acute phase of the inflammatory reaction, also with an antiproliferative effect, e.g. pentoxifylline.

The present invention discloses clerodendranthus spiatus extract for treating urinary calculus and its preparation process, and belongs to the field of Chinese herbal medicine extract and application technology. The clerodendranthus spiatus extract preparing process includes the following steps: soaking clerodendranthus spiatus in 4-10 times methanol to extract and concentrating to obtain extractum; dissolving the extractum in solvent in the same volume; extracting the solution first with petroleum ether and then with ethyl acetate and concentrating to obtain coarse extract; and chromatographic separation, eluting, collecting and concentrating to operate clerodendranthus spiatus extract A. The clerodendranthus spiatus extract A is liposoluble flavone glycoside compound and has obvious urinary calculus treating effects.

The invention discloses a medicament for treating dermatophytosis, especially applicable to the people who suffer from the dermatophytosis and work outside all day without a rest. The medicament for treating the dermatophytosis can remove the dermatophytosis fundamentally, detoxify and relieve the itching without side-effect. The components for preparing the compound medicament for treating dermatophytosis in percentage are: 40-60% of vitamin B, A 40-60% of vitamin, 10-30% of lightyellow sophora root, 10-30% of chinaberry bark, 6-20% of herba schizonepetae, 20-40% of rhizoma coptidis, 10-30% of Baikal skullcap root, 10-30% of amur corktree bark, 10-30% of artemisia capillaris, 40-80% of dried alum, 12-14% of borneol, 6-10% of sandalwood, 6-15% of curcuma zedoary, 26-70% of gypsum fibrosum, 20%-40% of cnidium monnieri, 1-3% of poria cocos, 1-3% of broom cypress fruit, 1-3% of periostracum cicada, 1-3% of cortex dictamni, 1-3% of flax kernel, 1-3% of amur corktree bark, 1-3% of angelica root, 1-3% of Sichuan pepper, 2-4% of dried alum, 2-4% of lithospermum, 0.5-3.5% of centipede, 5-15% of radix achyranthis bidentatae, 1-5% of root of stephaniatetrandraS.Moore, and 1-5% of akebia stem.

The invention relates to special complete formula feed for sows in the perinatal period. The feed comprises components including corn, fermented soybean meal, fermented peanut meal, oat, super steamed fish meal, egg powder, glucose, brown sugar, an emulsified fish oil-lard compound, seaweed meal, multivitamins, composite organic trace elements, a compound enzyme for pigs, choline chloride, lysine, ethoxyquinoline, phytase, salt, stone powder, calcium hydrophosphate, chitosan oligosaccharide, linseed meal, a cucubalus root-ricepaperplant pith-motherwort herb extract and mushroom powder. The feed effectively solves several common problems such as constipation, prolonged labor, postpartum lactation disorder and inadequate milk in the perinatal period of the sows, provides great help for pig farms for increase of the sow health level, the subsequent litter size and the utilization years as well as reduction of the labor intensity of workers for nursing of the sows in the perinatal period, and has very high economic significance and usage value.

The invention relates to a special compound feed for litopenaeus vannamei. The feed is composed of following components in percentage by weight: 18 to 24% of steam fish meal, 17 to 22% of soybean meal, 15 to 24% of peanut meal, 2 to 4% of spray-dried animal blood cells, 2 to 4% of squid paste, 2 to5% of yeast extract, 20 to 25% of flour, 2 to 3% of fish oil, 1 to 2% of soybean oil, 1.0% of shrimp multi-vitamin, 2.0% of shrimp multi-mineral and 1.0% of litopenaeus vannamei special feed addictive, and the sum of the components mentioned above is 100%. The nutrition composite of the compound feed is obtained from numerous tests according to the nutrition need of litopenaeus vannamei, can fully satisfy the nutrition need of litopenaeus vannamei, improves the immunity and disease preventing ability of litopenaeus vannamei, and promotes the healthy growth of litopenaeus vannamei.

The invention provides methods for treating pathological conditions associated with an undesirable inflammatory component. The invention is generally directed to reducing inflammation by administering cells that have one or more of the following effects in an injured subject: interact with splenocytes, preserve splenic mass, increase proliferation of CD4⁺ and CD8⁺ T-cells, increase IL-4 and IL-10, decrease IL-6 and IL-1β, and increase M2:M1 macrophage ratio at the site of injury. The invention is also directed to drug discovery methods to screen for agents that modulate the ability of the cells to have these effects. The invention is also directed to cell banks that can be used to provide cells for administration to a subject, the banks comprising cells having desired potency for achieving these effects.

The invention discloses a medical anti-adhesion membrane material with controllable degradation and a preparation method thereof, belonging to the field of biomedical materials. According to the invention, the membrane material is prepared by blending sodium hyaluronate and konjac klucomannan, using lactic acid as a property-modifying additive and using a mixed solution of ammonia water and anhydrous ethanol as a cross-linking agent; sodium hyaluronate is a good anti-adhesion material, but individually used sodium hyaluronate has a fast degradation speed and can not fulfill a good anti-adhesion effect; konjac klucomannan can control the degree of cross-linking, thereby realizing the goal of controllable degradation, and blending of sodium hyaluronate and konjac klucomannan enables sodium hyaluronate to be released slowly, thereby allowing the membrane material to meet demands for anti-adhesion action at different parts. The membrane material has the advantages of nontoxic degradation products, good biocompatibility, hygroscopicity and tensile properties, and the like, and can be used for intervertebral adhesion, intestinal adhesion, skin adhesion, intrauterine adhesion, etc.

An application of proanthocyanidin in preparing the medicines for treating ulcerative colitis and non-bacteria chronic colitis is disclosed.

The invention discloses a red kiwifruit room temperature storage and preservation operating method which comprises the following four steps: picking fresh red kiwifruits, preparing a preservative, dipping the fresh fruits and preserving the fresh fruits. The problems that the fresh red kiwifruits are difficult in room temperature storage and difficult in preservation are solved by utilizing a natural preservation method. According to the preservation operating method disclosed by the invention, due to two times of preservative liquid dipping treatment, dual-layer protection of a high-activity probiotics layer and a moisturizing and preservation antibacterial film is realized, skin shrinkage and fruit rot of the red kiwifruits are obviously controlled, the room temperature storage period and shelf life of the red kiwifruits are effectively prolonged, and the commodity value and economic benefits are improved; and moreover, the method can be popularized to be used in other fresh fruits.

An exterior-applied Chinese medicine for treating burn and local phyma and inflammation is prepared from 10 Chinese-medicinal materials including sanguisorba root, catechu, coptis root, myrrh, etc. Its advantages are high curative effect and no by-effect.